Sarilumab reduces disease activity in rheumatoid arthritis patients with inadequate response to janus kinase inhibitors or tocilizumab in regular care in Germany

por Tony, Hans-Peter, Feist, Eugen, Aries, Peer Malte, Zinke, Silke, Krüger, Klaus, Ahlers, Jonas, Albrecht, Inka, Barrionuevo, Christian, Kalus, Stefanie, Burkhardt, Harald
Publicado 2022